Antidepressant use during pregnancy and risk of congenital heart defects: A case‐time‐control study-Reference-Cited by-同舟云学术

Antidepressant use during pregnancy and risk of congenital heart defects: A case‐time‐control study

Published:2019-07-29 Issue:9 Volume:28 Page:1180-1193
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Sun Yuelian¹²³,Pedersen Lars Henning⁴,Wu Chun Sen⁵⁶,Petersen Irene¹⁷,Sørensen Henrik Toft¹,Olsen Jørn¹⁸

Affiliation:

1. Department of Clinical Epidemiology, Department of Clinical MedicineAarhus University Hospital Aarhus Denmark

2. Department of Neurology, Department of Clinical MedicineAarhus University Hospital Aarhus Denmark

3. National Center of Register‐based Research, Department of Economics and Business Economics, Business and Social ScienceAarhus University Aarhus Denmark

4. Department of Obstetrics and Gynecology, Department of Clinical MedicineAarhus University Hospital Aarhus Denmark

5. Research Unit of Gynecology and Obstetrics, Institute of Clinical ResearchUniversity of Southern Denmark Odense Denmark

6. Department of Obstetrics and GynecologyOdense University Hospital Odense Denmark

7. Department of Primary Care and Population HealthUniversity College London London UK

8. Department of Epidemiology, Fielding School of Public HealthUniversity of California, Los Angeles (UCLA) Los Angeles California USA

Funder

Novo Nordisk Fonden

Lundbeckfonden

European Commission

Kræftens Bekæmpelse

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.4844

Reference52 articles.

1. Maternal drug use in early pregnancy and infant cardiovascular defect

2. Paroxetine may increase risk for congenital malformations;Cuzzell JZ;Dermatol Nursing/Dermatol Nurses' Assoc,2006

3. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage

4. Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data

5. Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meta-analysis of risk factors for congenital heart disease – part 2: maternal medication, reproductive technologies, and familial and fetal factors.;Canadian Journal of Cardiology;2024-09

2. Concomitant use of antidepressants and benzodiazepines during pregnancy and associated risk of congenital malformations: a population-based cohort study in Taiwan;The Lancet Psychiatry;2024-08

3. Benzodiazepine Use During Pregnancy and Risk of Miscarriage;JAMA Psychiatry;2023-12-27

4. Evaluating the use of methods to mitigate bias from non‐transient medications in the case‐crossover design: A systematic review;Pharmacoepidemiology and Drug Safety;2023-06-15

5. Risk of delirium associated with antimuscarinics in older adults: A case‐time‐control study;Pharmacoepidemiology and Drug Safety;2022-05-25